跳至主要内容
临床试验/NCT00623207
NCT00623207已完成3 期

Safety and Feasibility of Atropine Added During Treadmill Stress Testing in Patients With Chronotropic Incompetence or Poor Exercise Capacity.

HaEmek Medical Center, Israel1 个研究点 分布在 1 个国家目标入组 103 人开始时间: 2007年12月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
3 期
状态
已完成
入组人数
103
试验地点
1
主要终点
1- To characterize patients who can't achieve target heart rate at treadmill exercise test.2- To evaluate atropine added during treadmill stress testing in order to increase heart rate and achieave conclusive test.

研究概览

简要总结

The aim of this study is to evaluate the Safety and feasibility of atropine added during treadmill stress testing in patients with chronotropic incompetence or poor exercise capacity.

Our hypothesis is that we can increase heart rate by using atropin in these patients, so we will achieve more conclusive results.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Single Group
主要目的
Diagnostic
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • Patients with chest pain without evidence of ischemia eligible for exercise test.
  • Age> 18 years old

排除标准

  • Patients with LBBB
  • Unstable Angina
  • Recent Myocardial Infarction
  • Un controlled Arrythmia
  • Congestive heart faliure
  • Severe symptomatic valvular heart disease
  • Acute Pulmonary Embolism
  • Acute perimyocarditis
  • Acute aortic dissection
  • Lt main stenosis
  • Severe hypertention (Systolic> 200 mmHg; Diastolic > 100 mmHg)
  • Cardiomyopathy
  • Obstructiove abnormalities
  • Psychiatric disorders
  • High degree AV Block

研究组 & 干预措施

1

Placebo Comparator

Pateints who achieve target haert rate or conclusive test will not be given Atropine

干预措施: Atropine (Drug)

2

Active Comparator

Patients who won't achieve tarhet heart rate or conclusive results will be given Atropine

干预措施: Atropine (Drug)

结局指标

主要结局

1- To characterize patients who can't achieve target heart rate at treadmill exercise test.2- To evaluate atropine added during treadmill stress testing in order to increase heart rate and achieave conclusive test.

时间窗: 1 yaer

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Mohamed Jabaren

MD

HaEmek Medical Center, Israel

研究点 (1)

Loading locations...

相似试验